Cambridge Newswire

Comprehensive Real-Time News Feed for Cambridge, MA.

Results 1 - 20 of 104 for "u:bloomberg.com" in Cambridge, MA

  1. Cuba Dissidents Want Focus to Stay on Human Rights RecordRead the original story

    Thursday Dec 18 | Bloomberg

    Americans excited about a U.S. detente with Cuba are thinking about buying cigars and visiting a colonial capital filled with Chevy's from the Eisenhower era. Dissidents want them to remember jailed protesters and human rights.

    Comment?

  2. Takeda Names Sanofi's Plump R&D Head as Yamada RetiresRead the original story

    Thursday Dec 18 | The Washington Post

    Plump, 49, senior vice president for research and translational medicine and a member of Sanofi's global leadership team, will join Takeda Feb. 1, Kazumi Kobayashi, a Takeda spokesman in Tokyo, said by telephone today. Plump, a U.S. national, will be based in Cambridge, Massachusetts, Kobayashi said.

    Comment?

  3. Apple Stops Online Sales in Russia Over Ruble FluctuationsRead the original story

    Tuesday Dec 16 | The Washington Post

    The iPhone and iPad maker stopped sales from its Web store as Russia's currency lost as much as 19 percent today, with a surprise interest-rate increase failing to stem a run on the currency. The ruble briefly sank beyond 80 per dollar, and bonds and stocks also tumbled.

    Comment?

  4. U.S. Getting Rid of Oil Addiction as Price Plummets in GlutRead the original story

    Thursday Dec 11 | The Washington Post

    The U.S. is producing the most oil in 31 years, economic growth is picking up and crude prices are plunging. So why is Americans' use of petroleum waning? As the U.S. moves closer and closer to energy independence, greater fuel efficiency, changing demographics and an increase in renewables are altering the dynamic that in the past would have seen demand for gasoline climbing. 1 comment

  5. America Getting Rid of Oil Addiction as Price Plummets Amid GlutRead the original story

    Wednesday Dec 10 | Bloomberg

    The U.S. is producing the most oil in 31 years, economic growth is picking up and crude prices are plunging. So why is Americans' use of petroleum waning? As the U.S. moves closer and closer to energy independence, greater fuel efficiency , changing demographics and an increase in renewables are altering the dynamic that in the past would have seen demand for gasoline climbing.

    Comment?

  6. Bluebird Soars as Gene Therapy Ends Transfusions in PatientsRead the original story

    Tuesday Dec 9 | The Washington Post

    Shares of Bluebird Bio Inc. soared to an all-time high after the company said its experimental gene therapy helped four patients with an inherited blood disorder go without regular blood transfusions. The four subjects had beta thalassemia major, a genetic condition in which the body doesn't produce enough hemoglobin to carry oxygen around the circulatory system.

    Comment?

  7. MIT Pulls Physicist's Online Courses in Sexual Harassment ProbeRead the original story

    Tuesday Dec 9 | Bloomberg

    Massachusetts Institute of Technology pulled the online courses of a well-known physicist after allegations that he sexually harassed at least one woman who was taking classes. MIT removed all courses and lectures by Walter Lewin from MIT OpenCourseWare and EdX, the online learning platform founded by MIT and Harvard University , it said today in a statement .

    Comment?

  8. Bluebird Soars as Gene Therapy Ends Transfusions in PatientsRead the original story

    Tuesday Dec 9 | The Washington Post

    Shares of Bluebird Bio Inc. soared to an all-time high after the company said its experimental gene therapy helped four patients with an inherited blood disorder go without regular blood transfusions. The four subjects had beta thalassemia major, a genetic condition in which the body doesn't produce enough hemoglobin to carry oxygen around the circulatory system.

    Comment?

  9. BlueBird Soars as Gene Therapy Ends Transfusion Need in PatientsRead the original story

    Monday Dec 8 | The Washington Post

    Shares of Bluebird Bio Inc. soared after the company said its experimental gene therapy helped four patients with an inherited blood disorder go without regular blood transfusions. The four subjects had beta thalassemia major, a genetic condition in which the body doesn't produce enough hemoglobin to carry oxygen around the circulatory system.

    Comment?

  10. Summers Sticks With Secular Stagnation Warning After Jobs DataRead the original story

    Friday Dec 5 | Bloomberg

    Former U.S. Treasury Secretary Lawrence Summers is sticking with his warning that the U.S. economy could be mired in an era of secular stagnation -- even after today's news of the biggest monthly job gains in almost three years. "When I put forward secular stagnation it wasn't to say that we were permanently doomed never to have a good month," Summers said in a brief telephone interview.

    Comment?

  11. Biogen Will Push Alzheimer's Drug to Phase 3Read the original story

    Tuesday Dec 2 | Bloomberg

    Biogen Idec Inc. shares rose after the company said its Alzheimer's drug showed promising early results and will be quickly moved into a final-stage trial. In a small, early stage trial, Biogen's drug BIIB037 reduced beta amyloid in the brain, said Doug Williams, executive vice president of research and development, at a Deutsche Bank conference in Boston today.

    Comment?

  12. Biogen Rises on Data From Early-Stage Alzheimer's Drug TrialRead the original story

    Tuesday Dec 2 | The Washington Post

    Biogen Idec Inc. shares rose after the company said its Alzheimer's drug showed promising early results and will be quickly moved into a final-stage trial. In a small, early stage trial, Biogen's drug BIIB037 reduced beta amyloid in the brain, said Doug Williams, executive vice president of research and development, at a Deutsche Bank conference in Boston today.

    Comment?

  13. Creatures of the Harvard-Yale Tailgate: A Photographic SurveyRead the original story w/Photo

    Nov 24, 2014 | Bloomberg

    Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions. Welcome to "The Game," that single day every year when rival factions of Ivy Leaguers dress up as sports fans and eat shrimp cocktail out of station wagons.

    Comment?

  14. In Battle of Sexes at Central Banks, Thai Women Have Already WonRead the original story

    Nov 24, 2014 | Bloomberg

    Janet Yellen 's appointment as Federal Reserve chair this year was hailed as another step toward gender equality. How about a central bank where women outnumber men? This is the Bank of Thailand , which runs monetary policy in Southeast Asia 's second-largest economy and has 31 women among its 60 executives.

    Comment?

  15. Ukraine Shrugged Off as ETF Swells to Record: Russia OvernightRead the original story

    Nov 23, 2014 | The Washington Post

    As oil fell into a bear market, the ruble traded at record lows and NATO said President Vladimir Putin is stoking conflict in Ukraine, bets on the biggest exchange-traded fund tracking Russian stocks surged to a record. Demand for shares in the Market Vectors Russia ETF has held up as investors look beyond the Ukraine conflict and position themselves for a rebound in stocks trading at the cheapest valuations in emerging markets.

    Comment?

  16. Sanofi's Sluggish Diabetes Growth Nips at Ambitious Product PlanRead the original story

    Nov 20, 2014 | The Washington Post

    Sanofi, which last month ousted its chief executive officer, unveiled plans to boost revenue by billions of dollars with 18 new products, an announcement overshadowed by concerns about prospects in diabetes. Revenue from diabetes treatments, which currently accounts for more than one-fifth of sales, will be flat to slightly higher through 2018, the Paris-based company said today.

    Comment?

  17. Sanofi Forecast for Flat Diabetes Sales Disappoints InvestorsRead the original story

    Nov 20, 2014 | The Washington Post

    Sanofi, the French drugmaker that fired Chief Executive Officer Chris Viehbacher last month, gave a sluggish long-term forecast for its diabetes drugs, a business that represents more than a fifth of its revenue. Sales from treatments for the disease will be flat to slightly growing through 2018, the Paris-based company said in a statement today.

    Comment?

  18. Sanofi Sees More Than $37 Billion in Sales From New DrugsRead the original story

    Nov 20, 2014 | The Washington Post

    Sanofi, the French drugmaker that fired Chief Executive Officer Chris Viehbacher last month, said new drugs it's developing may add a combined 30 billion euros in revenue over the first five years of sales. Sanofi may get approvals for as many as 18 products between 2014 and 2020, the Paris-based company said in a statement.

    Comment?

  19. Sanofi Said to Consider Smith & Nephew, Takeda Executives as CEORead the original story

    Nov 19, 2014 | The Washington Post

    Sanofi has considered Olivier Bohuon of medical-device maker Smith & Nephew Plc and Takeda Pharmaceutical Co.' s Christophe Weber as possible replacements for ousted Chief Executive Officer Chris Viehbacher, said people familiar with the situation.

    Comment?

  20. Harvard Receives Ballmer Funding to Expand Computer ScienceRead the original story

    Nov 13, 2014 | The Washington Post

    Harvard University will increase its faculty in computer science, the school's fastest-growing major, by 50 percent with funds from Steve Ballmer, Microsoft Corp.'s biggest shareholder and former chief executive officer. The gift will support 12 new teachers, increasing the size of the computer science faculty to 36, said David Parkes, area dean for computer science at Cambridge, Massachusetts-based Harvard.

    Comment?

Cambridge Job Listings
View or post Cambridge job listings on Topix.
Cambridge Real Estate
News, listings, and foreclosures in Cambridge from Topix.
Cambridge Mortgages
Find mortgage rates in Cambridge on Topix.